congenital pure red cell aplasia
Showing 1 - 25 of >10,000
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Diamond Blackfan Anemia, Pure Red Cell Aplasia Trial in Boston, Manhasset (Trifluoperazine)
Terminated
- Diamond Blackfan Anemia
- Pure Red Cell Aplasia
-
Boston, Massachusetts
- +1 more
Nov 18, 2022
Immunological Pure Red Cell Aplasia Trial (Isatuximab)
Not yet recruiting
- Immunological Pure Red Cell Aplasia
- (no location specified)
Sep 26, 2022
Pure Red Cell Aplasia Trial in Beijing (Sirolimus)
Completed
- Pure Red Cell Aplasia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 1, 2021
Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia Trial run by the NHLBI (Daclizumab)
Terminated
- Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
Acquired Pure Red Cell Aplasia Trial in Tianjin (bortezomib/dexamethasone)
Recruiting
- Acquired Pure Red Cell Aplasia
-
Tianjin, ChinaRegenerative Medicine Center
Sep 13, 2020
Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +2 more
-
Calgary, Alberta, CanadaAlberta Children's Hospital
May 25, 2021
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Stomatocytosis Trial in Le Kremlin Bicêtre
Recruiting
- Stomatocytosis
-
Le Kremlin Bicêtre, FranceAP-HP, Bicêtre Hospital, Pediatrics - Hematology - Reference cen
Oct 28, 2021
Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia, Evans Syndrome Trial in Beijing (Tacrolimus)
Unknown status
- Autoimmune Hemolytic Anemia
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 1, 2019
Diamond Blackfan Anemia Trial in Manhasset (Sotatercept, Sotatercept with prednisone boost)
Terminated
- Diamond Blackfan Anemia
- Sotatercept
- Sotatercept with prednisone boost
-
Manhasset, New YorkNorth Shore- LIJ campus of The Feinstein Institute for Medical R
Nov 22, 2021
Pyruvate Kinase Deficiency Trial in Stanford, Madrid (RP-L301)
Recruiting
- Pyruvate Kinase Deficiency
- RP-L301
-
Stanford, California
- +2 more
Sep 22, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell
No longer available
- Acute Lymphoblastic Leukemia
- +11 more
- CD34+ enriched, T Cell Depleted donor stem cell product
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 25, 2021
Parvovirus B19 Infection in Hereditary Hemolytic Anemias
Active, not recruiting
- Parvovirus B19 Infection
- Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG)
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Mar 25, 2021
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution
Recruiting
- Polycythemia Vera
-
Sohag, EgyptFaculty of Medicine
Aug 12, 2023
Osmotic Fragility in Red Blood Cells of Pediatric Cholestatic
Active, not recruiting
- Cholestasis
- Red Cell Membrane and Enzyme Abnormalities
- ektacytometry of red blood cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 12, 2022
Hematological Malignancy Trial (Thymoglobulin Injectable Product)
Not yet recruiting
- Hematological Malignancy
- Thymoglobulin Injectable Product
- (no location specified)
Sep 27, 2023
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia, Hemoglobinopathies Trial in San Francisco (in utero hematopoietic
Enrolling by invitation
- Alpha Thalassemia Major
- +8 more
- in utero hematopoietic stem cell transplantation
-
San Francisco, CaliforniaUniversity of California
Oct 28, 2022
Hematological Abnormalities in Children
Not yet recruiting
- Hematologic Diseases
- sampling
- (no location specified)
Sep 14, 2022
Vaginal Abnormality Trial (laparoscopy)
Not yet recruiting
- Vaginal Abnormality
- laparoscopy
- (no location specified)
May 18, 2022